These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8443920)

  • 1. Coronary atherosclerosis. A multifactorial disease.
    Badimon JJ; Fuster V; Chesebro JH; Badimon L
    Circulation; 1993 Mar; 87(3 Suppl):II3-16. PubMed ID: 8443920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathogenesis of the evolution of the atheroma plaque].
    Ferreira Montero IJ; Ferreira Aguar AI; Casasnovas Lenguas JA
    Rev Esp Cardiol; 1995; 48 Suppl 5():13-22. PubMed ID: 7494935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-pathological correlations of coronary disease progression and regression.
    Fuster V; Badimon JJ; Badimon L
    Circulation; 1992 Dec; 86(6 Suppl):III1-11. PubMed ID: 1424042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of coronary artery disease.
    Fernández-Ortiz A; Fuster V
    Clin Geriatr Med; 1996 Feb; 12(1):1-21. PubMed ID: 8653652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets, blood flow, and the vessel wall.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Circulation; 1990 Jan; 81(1 Suppl):I24-7; discussion I40-1. PubMed ID: 2403865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty.
    Adams PC; Badimon JJ; Badimon L; Chesebro JH; Fuster V
    Cardiovasc Clin; 1987; 18(1):49-71. PubMed ID: 2955894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cascade model for restenosis. A special case of atherosclerosis progression.
    Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK
    Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of atherosclerosis.
    Segrest JP; Anantharamaiah GM
    Curr Opin Cardiol; 1994 Jul; 9(4):404-10. PubMed ID: 7919584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present-day investigations cannot adequately determine the risk of acute coronary syndromes.
    Foo RS
    Clin Lab; 2001; 47(5-6):257-63. PubMed ID: 11405604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis.
    Fuster V; Griggs TR
    Prog Hemost Thromb; 1986; 8():159-83. PubMed ID: 3550894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should hemostatic factors be considered in the prevention of cardiovascular disease?].
    Musiał J; Duplaga M
    Pol Tyg Lek; 1993 Aug 2-16; 48(31-33):699-702. PubMed ID: 7971494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of experimental models for the development of clinical trials on thromboatherosclerosis.
    Fuster V; Ip JH; Badimon L; Badimon JJ; Stein B; Chesebro JH
    Circulation; 1991 Jun; 83(6 Suppl):IV15-25. PubMed ID: 1645625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease: pathogenesis and acute coronary syndromes.
    Worthley SG; Osende JI; Helft G; Badimon JJ; Fuster V
    Mt Sinai J Med; 2001 May; 68(3):167-81. PubMed ID: 11373689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of acute coronary syndrome].
    Lüscher TF; Wenzel RR
    Praxis (Bern 1994); 1995 Feb; 84(6):155-64. PubMed ID: 7871298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do plaques rupture?
    Falk E
    Circulation; 1992 Dec; 86(6 Suppl):III30-42. PubMed ID: 1424049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The three mechanisms for coronary artery disease progression: insights into future management.
    McLaughlin MA; Fuster V
    Mt Sinai J Med; 1995 Sep; 62(4):265-74. PubMed ID: 7565849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.